Tofacitinib: a janus kinase inhibitor for rheumatoid arthritis
This article discusses its properties, efficacy and adverse effects. (Source: Prescriber)
Source: Prescriber - August 29, 2017 Category: Primary Care Authors: Steve Chaplin Tags: New Product Source Type: research
Brexit means Brexit, but what of pharmacovigilance?
While uncertainty remains over exactly how the UK's exit from the European Union will pan out, there is little doubt that there will be disruption, at least in the short term, for the pharmaceutical industry. Issues surrounding the potential implications of Brexit for the medicines regulatory system, and for pharmacovigilance in particular, were discussed at a recent meeting in London, organised by the Drug Safety Research Unit. Steve Titmarsh reports. (Source: Prescriber)
Source: Prescriber - August 29, 2017 Category: Primary Care Authors: Steve Titmarsh Tags: Conference Report Source Type: research
Efficacy and side ‐effects of oral contraceptives
For the majority of women, oral contraception is safe, convenient and effective, but users should be counselled about potential adverse effects and the importance of good adherence. This review discusses the efficacy, advantages and disadvantages of both combined and progestogen‐only oral contraceptives. (Source: Prescriber)
Source: Prescriber - August 29, 2017 Category: Primary Care Authors: Anne MacGregor Tags: Drug Review Source Type: research
Administering steroids with HIV treatment ‐boosting agents
This article discusses the strategies to help prevent this and describes how to identify and manage such interactions. (Source: Prescriber)
Source: Prescriber - August 29, 2017 Category: Primary Care Authors: Gurmit Kaur Jagjit Singh, Rachael Jones, Kevin Shotliff Tags: Prescribing in Practice Source Type: research
How will NICE's budget impact test affect new drug availability?
NICE's budget impact test – in which new drugs that will have a net impact of £20 million or more in any one of their first three years of use will trigger commercial negotiations between NHS England and the drug company – was introduced in April, amid much controversy. Many argue the threshold is too low and will have an unacceptable impact on the availability of new medicines. (Source: Prescriber)
Source: Prescriber - August 29, 2017 Category: Primary Care Authors: Joy Ogden Tags: Analysis Source Type: research
Pharma, the NHS and our learned friends
(Source: Prescriber)
Source: Prescriber - August 1, 2017 Category: Primary Care Authors: Rob Munro Tags: Editorial Source Type: research
One patient at a time, please!
‘Two for the price of one’ is not a tempting offer when it comes to patient appointments, as Dr David Delvin explains. (Source: Prescriber)
Source: Prescriber - July 31, 2017 Category: Primary Care Authors: David Delvin Tags: Postscript Source Type: research
Fiasp: a new faster ‐acting insulin aspart formulation for diabetes
This article describes its properties, efficacy and adverse effects. (Source: Prescriber)
Source: Prescriber - July 31, 2017 Category: Primary Care Authors: Steve Chaplin Tags: New Product Source Type: research
Deprescribing: tackling increasing polypharmacy
“Deprescribing – is less more?” was the theme of this year's annual scientific meeting organised by the Prescribing and Research in Medicines Management (PRIMM) group, held in London in January. The meeting covered a range of topics relating to deprescribing, including a seven‐step deprescribing model, identifying patients with polypharmacy problems, and providing individualised prescribing. (Source: Prescriber)
Source: Prescriber - July 31, 2017 Category: Primary Care Authors: Janet Krska, Rachel Howard, Nina Barnett Tags: Conference Report Source Type: research
Perceptions of the Drug Safety Update newsletter
The Drug Safety Update newsletter, published monthly by the MHRA, plays an important role in alerting health professionals to new safety information on medicines. Mike Wilcock and Georgina Praed present the findings of their small survey of GPs, nurse prescribers and community pharmacists to gauge their awareness and views of the Drug Safety Update newsletter. (Source: Prescriber)
Source: Prescriber - July 31, 2017 Category: Primary Care Authors: Mike Wilcock, Georgina Praed Tags: Survey Source Type: research
Findings of the National Diabetes Inpatient Audit 2016
The National Diabetes Inpatient Audit's latest findings on the quality of diabetes care provided to patients while they are in hospital in England and Wales highlights many areas where there is room for improvement, but inpatients remain mainly positive about their overall care. (Source: Prescriber)
Source: Prescriber - July 31, 2017 Category: Primary Care Authors: Steve Chaplin Tags: Analysis Source Type: research
Causes and treatment of nausea and vomiting
This article discusses the various causes of nausea and vomiting and the treatment options available. (Source: Prescriber)
Source: Prescriber - July 31, 2017 Category: Primary Care Authors: Aaron Bhakta, Rishi Goel Tags: Drug Review Source Type: research
Assessment and management of Raynaud's phenomenon
This article discusses the assessment and treatment of RP and the GP's role in management. (Source: Prescriber)
Source: Prescriber - July 31, 2017 Category: Primary Care Authors: Michael Hughes, Ariane L Herrick Tags: Prescribing in Practice Source Type: research
Drug safety – a problem of communication
(Source: Prescriber)
Source: Prescriber - July 1, 2017 Category: Primary Care Authors: Rob Munro Tags: Editorial Source Type: research
Addressing the problem of undressing
When it comes to asking reluctant patients to undress for an examination, Dr David Delvin opts for a straightforward, no‐nonsense approach. (Source: Prescriber)
Source: Prescriber - June 30, 2017 Category: Primary Care Authors: David Delvin Tags: Postscript Source Type: research
